ESR1 and breast cancer: Based on published reports of PR isoform-specific ER/PR crosstalk observed using artificial vector constructs [33–38] and our findings of different biologies for the two PR isoforms in breast cancer cells (Figure 1), we hypothesized that these isoforms differentially reprogram estrogen signaling.